bonyf NV: 25% increase in turnover in H1 2022
- 109
|
bonyf NV
25% increase in turnover in H1 2022
Continued commercial efforts to attain new customers Ghent (Belgium), 14 September 2022, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces a strong growth in turnover for the first half of 2022 compared to the first half of 2021.
The 2021 financial year showed a comparative growth of 14% for bonyf. This trend has accelerated in the first half of 2022 with invoicing of €1,406K, ie. an increase of 25%. bonyf benefited from the favourable sales trend of its OlivaFix range of denture adhesive creams, which grew by more than 37% to €250K over the H1 period. Containing 30% olive oil, the OlivaFix range of adhesive creams are safer than most denture adhesive creams found on the market, which contain a variety of petrochemicals. One of the most common ingredients in denture adhesive creams is petrolatum, also known as vaseline/petroleum jelly, a potential carcinogenic, according to the office ECHA website (https://echa.europa.eu/fr/substance-information/-/substanceinfo/100.029.428) bonyf appointed Mr Ben Mettepenningen as International Business Manager to support its growth trajectory resulting in promising prospects in several countries. The company will continue its business development policy based on the launch of new innovative products and the acquisition of strategic customers. While taking into account the adverse effects of inflation, bonyf confirms its objective of achieving a strong growth in turnover. bonyf’s strengths
About bonyf
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. Learn more at https://bonyf.com
Regulatory filing PDF file File: bonyf PR S1 Revenue 2022 |
| Language: | English |
| Company: | bonyf NV |
| Doornzelestraat 114 D | |
| 9000 Gent | |
| Belgium | |
| Phone: | +41 79 412 42 79 |
| E-mail: | [email protected] |
| Internet: | www.bonyf.com |
| ISIN: | BE6333353298 |
| Euronext Ticker: | MLBON |
| AMF Category: | Inside information / Other releases |
| EQS News ID: | 1442717 |
| End of Announcement | EQS News Service |
1442717 14-Sep-2022 CET/CEST
EQS Group
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.
